Cambridge / Judge - 11-17-2023 | Clear Admit ApplyWire

November 17, 2023 12:01pm ET

Applying: Cambridge / Judge, Carnegie Mellon / Tepper, Duke / Fuqua, Georgetown / McDonough

Intake Year: 2024

Pre-MBA Career: Regulatory compliance at Deloitte, dealing with pharmaceutical clients

Post-MBA Target Industry: Consulting, Pharmaceutical Companies: AT Kearney , BCG , Deloitte , KPMG , McKinsey , PWC , Amgen , Astra Zeneca , Johnson & Johnson , Merck , Novartis , Pfizer , Roche

GRE: 312

GPA: 3/4

Years of Work Experience: 5

Location: India

Post MBA Location: Europe/India

Notes:

Retook GRE today and scored abysmally even after scoring 320 (highest) on mocks. Do not plan on retaking. I know it pulls my profile down.

Like (1)

Show Comments (2) Last: November 21, 2023

alexbr4 Verified User. Likes Earned: 1461 What is your GPA? The combo of GRE and GPA is going to be important, and may be limiting.

Are you targeting Round 2, or have you already applied? Round 2 May also add challenges if you’re considered over-represented.

Showing impact and growth at work is important. Are you also involved in activities outside of work?

(0)

grichmond Verified User. Likes Earned: 1060 Following Alex's question: where did you attend ugrad and what was the grading system? Is 3/4 a 3.0/4.0 or a 75%?

In all cases, for better or for worse, if you are applying in R2 this year, as an Indian national, you are likely to face stiff competition as an ORM, and this is where the GRE result may hurt you. At minimum you may need to cast a wider net in terms of the number and type of target programs.
(0)